-+ 0.00%
-+ 0.00%
-+ 0.00%

Rezolute To Present Four Presentations At Upcoming Annual Meeting Of Endocrine Society

Benzinga·06/04/2026 11:35:49
Listen to the news

Rezolute, Inc. (NASDAQ:RZLT) ("Rezolute" or the "Company"), a late-stage ultra-rare disease company focused on treating refractory hypoglycemia caused by a congenital or any acquired form of hyperinsulinism (HI), today announced four presentations at the upcoming Annual Meeting of the Endocrine Society (ENDO) being held June 13-16, 2026, in Chicago, IL.